Technology Roadmap: Pharmaceutical Product Development & Manufacturing I
The FDA Critical Path Initiative has identified the lack of innovative technology in pharmaceutical product development and manufacture to be a major impediment to reducing time to market as well as cost of drugs. In response to this Initiative, the National Institute for Pharamceutical Technology & Education, a non-for-profit organization, in cooperation with ISPE and the FDA has undertaken development of a Technology Roadmap which identifies specific research needs in these technology domains. In this session two of the main areas of the draft roadmap ( pharmaceutical materials and product development) will be reviewed and feedback sollicited from the ChE research community.
Paper abstracts are public but to access Extended Abstracts, you must first purchase the conference proceedings.
Do you already own this?
Log In for instructions on accessing this content.
|AIChE Graduate Student Members||Free|
|AIChE Undergraduate Student Members||Free|